Naltrexone
Alcohol Dependence
Inventage Lab., Inc.Small moleculePhase 4 / ApprovedActive
BBB
79/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 73/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Alcohol Dependence cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Acamprosate Hanyang University Seoul Hospital | Phase 4 | BBB |
Escitalopram University of Texas Southwestern Medical Center | Phase 4 | BBB |
QUETIAPINE University of Texas Southwestern Medical Center | Phase 4 | BBB |
Topiramate Stanford University | Phase 4 | BB |
Fluoxetine New York State Psychiatric Institute | Phase 4 | BB |
View all 26 →
Same molecule, other indications
Naltrexone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →